The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients
Sponsor: Oslo University Hospital
Listed as NCT04321616, this PHASE2/PHASE3 trial focuses on Acute Respiratory Distress Syndrome ARDS and COVID 19 and remains ongoing. Sponsored by Oslo University Hospital, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2022 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting PHASE2_PHASE3
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Apr 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oslo University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .